Rating History for Orexigen Therapeutics (OREX) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for OREX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/16/2016 N/A Downgrade Neutral
(Overweight)		 2.00
(5.00)		 0.64
(0.22)		 -65.63% Details